Literature DB >> 10096045

Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies.

B H Juurlink1, P G Paterson.   

Abstract

Much of the damage that occurs in the central nervous system (CNS) following trauma is due to secondary effects of glutamate excitotoxicity, Ca2+ overload, and oxidative stress, three mechanisms that in a spiraling interactive cascade end in neuronal death. Oxidative stress activates mechanisms that result in a neutrophil-mediated inflammation that also causes secondary damage. Mechanisms of oxidative stress are reviewed, with particular attention paid to lipid peroxidation and the central role of reduced glutathione in scavenging peroxides. We suggest that decreasing oxidative stress will greatly reduce the amount of secondary damage due to trauma. Oxidative stress can be minimized by 1) maintaining reduced-glutathione levels through the administration of cysteine precursors such as N-acetylcysteine and 2) limiting neutrophil invasion by administering platelet-activating factor antagonists such as BN 52021. Aggressive nutritional support following CNS trauma can also contribute to maximizing antioxidant defenses. Furthermore, we suggest that flavonoids such as quercetin have the potential to be therapeutically effective because of their free radical quenching, iron chelating, and anti-inflammatory properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10096045     DOI: 10.1080/10790268.1998.11719540

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  60 in total

1.  Neuroprotective effects of N-acetylcysteine on experimental closed head trauma in rats.

Authors:  Tufan Hicdonmez; Mehmet Kanter; Mehmet Tiryaki; Turgay Parsak; Sebahattin Cobanoglu
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

Review 2.  Neurological and neuropsychological consequences of electrical and lightning shock: review and theories of causation.

Authors:  Christopher J Andrews; Andrew D Reisner
Journal:  Neural Regen Res       Date:  2017-05       Impact factor: 5.135

Review 3.  Modern Medical Management of Spinal Cord Injury.

Authors:  Michael Karsy; Gregory Hawryluk
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-30       Impact factor: 5.081

4.  Nuclear translocation of PKM2 modulates astrocyte proliferation via p27 and -catenin pathway after spinal cord injury.

Authors:  Jinlong Zhang; Guijuan Feng; Guofeng Bao; Guanhua Xu; Yuyu Sun; Weidong Li; Lingling Wang; Jiajia Chen; Huricha Jin; Zhiming Cui
Journal:  Cell Cycle       Date:  2015-07-07       Impact factor: 4.534

5.  Gelsolin levels are increased in the brain as a function of age during normal development in children that are further increased in Down syndrome.

Authors:  Lina Ji; Abha Chauhan; Balu Muthaiyah; Jerzy Wegiel; Ved Chauhan
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

6.  Loss of astrocytic glutamate transporters in Wernicke encephalopathy.

Authors:  Alan S Hazell; Donna Sheedy; Raluca Oanea; Meghmik Aghourian; Simon Sun; Jee Yong Jung; Dongmei Wang; Chunlei Wang
Journal:  Glia       Date:  2010-01-15       Impact factor: 7.452

7.  Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury.

Authors:  Sang Mi Lee; Steven Rosen; Philip Weinstein; Nico van Rooijen; Linda J Noble-Haeusslein
Journal:  J Neurotrauma       Date:  2011-08-08       Impact factor: 5.269

8.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

9.  Management of oxidative stress in the CNS: the many roles of glutathione.

Authors:  B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

10.  Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity.

Authors:  Kimberly R Byrnes; Bogdan Stoica; David J Loane; Angela Riccio; Margaret I Davis; Alan I Faden
Journal:  Glia       Date:  2009-04-01       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.